Skip to main content

Advertisement

Log in

The Role of Phospholipase D1 in Liver Fibrosis Induced by Dimethylnitrosamine In Vivo

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background

Phospholipase D (PLD) has been proved to be involved in regulating function of fibroblasts and might play a role in mediating organic fibrosis.

Aims

To investigate the role and mechanism of PLD on dimethylnitrosamine (DMN)-induced rat liver fibrosis.

Methods

Fifty-five male Wistar rats were divided into normal control group, DMN model group, N-methylethanolamine (MEA) control group, and MEA-intervention group. We observed the effects of MEA, a PLD inhibitor on the development and progression of rat liver fibrosis by comparing the physical and biochemical indexes, tissue pathology, PLD activity, and typical markers and cytokines related to fibrosis in the four groups.

Results

Accompanied by the down-regulation of PLD1 expression, the MEA-intervention group had improved outcomes compared with the DMN model group in terms of spleen weight, spleen/weight index, serum and tissue biochemical indexes, tissue hydroxyproline, and tissue pathology. The MEA-intervention group had lower TIMP1, COL1A1, and higher MMPs expression level than the DMN model group. The activity of PLD and PLD1, α-SMA expression level in the MEA-intervention group was much lower than those in the DMN model group. There was no significant difference between the two groups in the expression level of TGF-β1 and MCP1. Meanwhile, there were no significant differences between normal control group and MEA control group in the parameters stated above.

Conclusion

Phospholipase D1 may play an important role in the development and progression of rat liver fibrosis. Inhibition of PLD may become a new strategy to prevent or alleviate liver fibrosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology. 2008;134:1655–1669.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  2. McDermott M, Wakelam MJ, Morris AJ. Phospholipase D. Biochem Cell Biol. 2004;82:225–253.

    Article  CAS  PubMed  Google Scholar 

  3. Liscovitch M, Czarny M, Fiucci G, et al. Phospholipase D: molecular and cell biology of a novel gene family. Biochem J. 2000;345:401–415.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  4. Exton JH. Phospholipase D-structure, regulation and function. Rev Physiol Biochem Pharmacol. 2002;144:1–94.

    Article  CAS  PubMed  Google Scholar 

  5. Jenkins GM, Frohman MA. Phospholipase D a lipid centric review. Cell Mol Life Sci. 2005;62:2305–2316.

    Article  CAS  PubMed  Google Scholar 

  6. Roth MG. Molecular mechanisms of PLD function in membrane traffic. Traffic. 2008;9:1233–1239.

    Article  CAS  PubMed  Google Scholar 

  7. Komati H, Naro F, Mebarek S, et al. Phospholipase D is involved in myogenic differentiation through remodeling of actin cytoskeleton. Mol Biol Cell. 2005;16:1232–1244.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. Rudge SA, Wakelam MJ. Inter-regulatory dynamics of phospholipase D and the actin cytoskeleton. Biochim Biophys Acta. 2009;1791:856–861.

    Article  CAS  PubMed  Google Scholar 

  9. Chae YC, Kim JH, Kim KL, et al. Phospholipase D activity regulates integrin-mediated cell spreading and migration by inducing GTP-Rac translocation to the plasma membrane. Mol Biol Cell. 2008;19:3111–3123.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  10. Horstmeyer A, Licht C, Scherr G, et al. Signalling and regulation of collagen I synthesis by ET-1 and TGF-beta1. FEBS J. 2005;272:6297–6309.

    Article  CAS  PubMed  Google Scholar 

  11. Andersson L, Bostrom P, Ericson J, et al. PLD1 and ERK2 regulate cytosolic lipid droplet formation. J Cell Sci. 2006;119:2246–2257.

    Article  CAS  PubMed  Google Scholar 

  12. Marchesan D, Rutberg M, Andersson L, et al. A phospholipase D-dependent process forms lipid droplets containing caveolin, adipocyte differentiation-related protein, and vimentin in a cell-free system. J Biol Chem. 2003;278:27293–27300.

    Article  CAS  PubMed  Google Scholar 

  13. Lee S, Park JB, Kim JH, et al. Actin directly interacts with phospholipase D, inhibiting its activity. J Biol Chem. 2001;276:28252–28260.

    Article  CAS  PubMed  Google Scholar 

  14. Kam Y, Exton JH. Phospholipase D activity is required for actin stress fiber formation in fibroblasts. Mol Cell Biol. 2001;21:4055–4066.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  15. Pilquil C, Dewald J, Cherney A, et al. Lipid phosphate phosphatase-1 regulates lysophosphatidate-induced fibroblast migration by controlling phospholipase D2-dependent phosphatidate generation. J Biol Chem. 2006;281:38418–38429.

    Article  CAS  PubMed  Google Scholar 

  16. Yamamoto K, Takahashi Y, Mano T, et al. N-methylethanolamine attenuates cardiac fibrosis and improves diastolic function: inhibition of phospholipase D as a possible mechanism. Eur Heart J. 2004;25:1221–1229.

    Article  CAS  PubMed  Google Scholar 

  17. Baroni GS, D’Ambrosio L, Curto P, et al. Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis. Hepatology. 1996;23:1189–1199.

    Article  CAS  PubMed  Google Scholar 

  18. Brunt EM. Grading and staging the histopathological lesions of chronic hepatitis: the Knodell histology activity index and beyond. Hepatology. 2000;31:241–246.

    Article  CAS  PubMed  Google Scholar 

  19. Itoh S, ten Dijke P. Negative regulation of TGF-beta receptor/Smad signal transduction. Curr Opin Cell Biol. 2007;19:176–184.

    Article  CAS  PubMed  Google Scholar 

  20. Hu P-F, Zhu Y-W, Zhong W, et al. Inhibition of plasminogen activator inhibitor-1 expression by siRNA in rat hepatic stellate cells. J Gastroenterol Hepatol. 2008;23:1917–1925.

    Article  CAS  PubMed  Google Scholar 

  21. Trebicka J, Racz I, Siegmund SV, et al. Role of cannabinoid receptors in alcoholic hepatic injury: steatosis and fibrogenesis are increased in CB2 receptor-deficient mice and decreased in CB1 receptor knockouts. Liver Int. 2011;31:860–870.

    Article  CAS  PubMed  Google Scholar 

  22. Benitez-Rajal J, Lorite MJ, Burt AD, et al. Phospholipase D and extracellular signal-regulated kinase in hepatic stellate cells: effects of platelet-derived growth factor and extracellular nucleotides. Am J Physiol Gastrointest Liver Physiol. 2006;291:G977–G986.

    Article  CAS  PubMed  Google Scholar 

  23. Seki E, De Minicis S, Osterreicher CH, et al. TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med. 2007;13:1324–1332.

    Article  CAS  PubMed  Google Scholar 

  24. Du G, Altshuller YM, Kim Y, et al. Dual requirement for rho and protein kinase C in direct activation of phospholipase D1 through G protein-coupled receptor signaling. Mol Biol Cell. 2000;11:4359–4368.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  25. Colley WC, Sung TC, Roll R, et al. Phospholipase D2, a distinct phospholipase D isoform with novel regulatory properties that provokes cytoskeletal reorganization. Curr Biol. 1997;7:191–201.

    Article  CAS  PubMed  Google Scholar 

  26. Du G, Huang P, Liang BT, et al. Phospholipase D2 localizes to the plasma membrane and regulates angiotensin II receptor endocytosis. Mol Biol Cell. 2004;15:1024–1030.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  27. Freyberg Z, Sweeney D, Siddhanta A, et al. Intracellular localization of phospholipase D1 in mammalian cells. Mol Biol Cell. 2001;12:943–955.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  28. Noh DY, Ahn SJ, Lee RA, et al. Overexpression of phospholipase D1 in human breast cancer tissues. Cancer Lett. 2000;161:207–214.

    Article  CAS  PubMed  Google Scholar 

  29. Wood LD, Parsons DW, Jones S, et al. The genomic landscapes of human breast and colorectal cancers. Science. 2007;318:1108–1113.

    Article  CAS  PubMed  Google Scholar 

  30. Saito M, Iwadate M, Higashimoto M, et al. Expression of phospholipase D2 in human colorectal carcinoma. Oncol Rep. 2007;18:1329–1334.

    CAS  PubMed  Google Scholar 

  31. Zhao Y, Ehara H, Akao Y, et al. Increased activity and intranuclear expression of phospholipase D2 in human renal cancer. Biochem Biophys Res Commun. 2000;278:140–143.

    Article  CAS  PubMed  Google Scholar 

  32. Cai D, Zhong M, Wang R, et al. Phospholipase D1 corrects impaired betaAPP trafficking and neurite outgrowth in familial Alzheimer’s disease-linked presenilin-1 mutant neurons. Proc Natl Acad Sci USA. 2006;103:1936–1940.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  33. Gorbatyuk OS, Li S, Nha Nguyen F, et al. Alpha-Synuclein expression in rat substantia nigra suppresses phospholipase D2 toxicity and nigral neurodegeneration. Mol Ther. 2010;18:1758–1768.

    Google Scholar 

  34. Oliveira TG, Chan RB, Tian H, et al. Phospholipase d2 ablation ameliorates Alzheimer’s disease-linked synaptic dysfunction and cognitive deficits. J Neurosci. 2010;30:16419–16428.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  35. Zhang Y, Kanaho Y, Frohman MA, et al. Phospholipase D1-promoted release of tissue plasminogen activator facilitates neurite outgrowth. J Neurosci. 2005;25:1797–1805.

    Article  CAS  PubMed  Google Scholar 

  36. Vorland M, Holmsen H. Phospholipase D in human platelets: presence of isoenzymes and participation of autocrine stimulation during thrombin activation. Platelets. 2008;19:211–224.

    Article  CAS  PubMed  Google Scholar 

  37. Vorland M, Holmsen H. Phospholipase D activity in human platelets is inhibited by protein kinase A, involving inhibition of phospholipase D1 translocation. Platelets. 2008;19:300–307.

    Article  CAS  PubMed  Google Scholar 

  38. Su W, Chen Q, Frohman MA. Targeting phospholipase D with small-molecule inhibitors as a potential therapeutic approach for cancer metastasis. Future Oncol. 2009;5:1477–1486.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  39. Elvers M, Stegner D, Hagedorn I, et al. Impaired alpha(IIb)beta(3) integrin activation and shear-dependent thrombus formation in mice lacking phospholipase D1. Sci Signal. 2010;3:ra1.

    Google Scholar 

  40. Hong KW, Jin HS, Lim JE, et al. Non-synonymous single-nucleotide polymorphisms associated with blood pressure and hypertension. J Hum Hypertens. 2010;24:763–774.

    Article  CAS  PubMed  Google Scholar 

  41. Tsukahara T, Tsukahara R, Fujiwara Y, et al. Phospholipase D2-dependent inhibition of the nuclear hormone receptor PPARgamma by cyclic phosphatidic acid. Mol Cell. 2010;39:421–432.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  42. Disse J, Vitale N, Bader MF, et al. Phospholipase D1 is specifically required for regulated secretion of von Willebrand factor from endothelial cells. Blood. 2009;113:973–980.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by grants from the National Natural Science Foundation of China (No. 81170406), Shanghai Natural Science Foundation by Shanghai Science and Technology Commission (No. 11ZR1433500), and the Wangbaoen Fund of Chinese Foundation for Hepatitis Prevention and Control (No. 20100029).

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Wenzhuo Yang.

Additional information

Xinyan Zhu and Ruilin Liu contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhu, X., Liu, R., Kuang, D. et al. The Role of Phospholipase D1 in Liver Fibrosis Induced by Dimethylnitrosamine In Vivo. Dig Dis Sci 59, 1779–1788 (2014). https://doi.org/10.1007/s10620-014-3130-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-014-3130-6

Keywords

Navigation